Humanin vs NMN (Nicotinamide Mononucleotide)
Overview
Humanin is primarily a anti-aging & longevity peptide, while NMN (Nicotinamide Mononucleotide) is used for anti-aging & longevity.
This page compares Humanin and NMN (Nicotinamide Mononucleotide) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Humanin | NMN (Nicotinamide Mononucleotide) | |
|---|---|---|
| Category | Anti-aging & Longevity | Anti-aging & Longevity |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | Research phase | 250-500 mg |
| Frequency | research | Daily oral or subQ |
| Reported benefits | Neuroprotection, metabolic health, potential longevity extension, alzheimer's protection | NAD+ repletion, mitochondrial biogenesis, sirtuin activation, DNA repair. |
| Reported side effects | Research phase. Safety profile being established | Generally well-tolerated; rare GI discomfort. |
Key differences
Primary use. Humanin is categorised under Anti-aging & Longevity, while NMN (Nicotinamide Mononucleotide) falls under Anti-aging & Longevity. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Humanin: not FDA-approved; treated as a research compound. NMN (Nicotinamide Mononucleotide): not FDA-approved; treated as a research compound.
Dosing. Humanin is typically dosed at Research phase (research). NMN (Nicotinamide Mononucleotide) is typically dosed at 250-500 mg (Daily oral or subQ).
Can you stack them?
Some protocols combine peptides, but stacking Humanin and NMN (Nicotinamide Mononucleotide) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Humanin and NMN (Nicotinamide Mononucleotide)?
- Humanin is primarily a anti-aging & longevity peptide, while NMN (Nicotinamide Mononucleotide) is used for anti-aging & longevity. Humanin is not FDA-approved; generally classified as a research compound, whereas NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound.
- What is Humanin used for?
- Mitochondrial protection, longevity.
- What is NMN (Nicotinamide Mononucleotide) used for?
- NAD+ direct precursor nucleotide; key longevity compound.
- Can you take Humanin and NMN (Nicotinamide Mononucleotide) together?
- Some users combine peptides within a single protocol, but stacking Humanin and NMN (Nicotinamide Mononucleotide) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Humanin or NMN (Nicotinamide Mononucleotide) FDA-approved?
- Humanin is not FDA-approved; generally classified as a research compound. NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound.
Read the full articles
- Humanin — full monograph: mechanism, research, dosing & references
- NMN (Nicotinamide Mononucleotide) — full monograph: mechanism, research, dosing & references